Our research strategy
Funding research into mitochondrial disease in order to improve lives is a key element of our strategy.
Since The Lily Foundation began back in 2007, funding cutting-edge research has always been a key element of our strategy. Not only does research help us to understand more about the complexities of mitochondrial disease, but it also brings life-changing benefits to patients and their families, and holds the key to finding effective treatments and, ultimately, a cure.
The Lily Foundation are the largest charitable funder of mitochondrial disease research in Europe, and our funding strategy focuses on two key areas – improving diagnosis and finding treatments.
Funding research into mitochondrial disease in order to improve lives is a key element of our strategy.
So far we’ve funded over 20 research projects in our search for treatments and a cure for mito.
Here you’ll find details of research studies and clinical trials into mito that are currently taking place.
We’re proud to work with leading research institutions in seeking a cure for mitochondrial disease.
Get involved and discover all the ways the patient voice can be heard in mitochondrial research.
Your hub for the latest news, views and breakthroughs in mitochondrial disease research.
If you have any problems please email [email protected]